WO2001084962A3 - Zusammensetzungen enthaltend folsäure und reduziertes folat - Google Patents

Zusammensetzungen enthaltend folsäure und reduziertes folat Download PDF

Info

Publication number
WO2001084962A3
WO2001084962A3 PCT/EP2001/004984 EP0104984W WO0184962A3 WO 2001084962 A3 WO2001084962 A3 WO 2001084962A3 EP 0104984 W EP0104984 W EP 0104984W WO 0184962 A3 WO0184962 A3 WO 0184962A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions containing
folic acid
containing folic
reduced folate
acid
Prior art date
Application number
PCT/EP2001/004984
Other languages
English (en)
French (fr)
Other versions
WO2001084962A2 (de
Inventor
Wolfgang Haehnlein
Klaus Kraemer
Oliver Hasselwander
Loni Schweikert
Original Assignee
Basf Ag
Wolfgang Haehnlein
Klaus Kraemer
Oliver Hasselwander
Loni Schweikert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag, Wolfgang Haehnlein, Klaus Kraemer, Oliver Hasselwander, Loni Schweikert filed Critical Basf Ag
Priority to EP01949308A priority Critical patent/EP1282366A2/de
Priority to CA002408401A priority patent/CA2408401A1/en
Priority to AU70501/01A priority patent/AU782556B2/en
Priority to US10/275,566 priority patent/US6921754B2/en
Priority to JP2001581632A priority patent/JP2003532655A/ja
Publication of WO2001084962A2 publication Critical patent/WO2001084962A2/de
Publication of WO2001084962A3 publication Critical patent/WO2001084962A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
    • A23C9/158—Milk preparations; Milk powder or milk powder preparations containing additives containing vitamins or antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pediatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Vorgeschlagen werden Zusammensetzungen, die Folsäure in Kombination mit 5-Methyltetrahydrofolsäure enthalten sowie Zusammensetzungen, die Folsäure, 5-Methyltetrahydrofolsäure und/oder 5-Methyltetrahydrofolsäurepolyglutamat sowie eine Nahrungskomponente und/oder eine Nährstoffzubereitung enthalten sowie deren Verwendung.
PCT/EP2001/004984 2000-05-10 2001-05-03 Zusammensetzungen enthaltend folsäure und reduziertes folat WO2001084962A2 (de)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP01949308A EP1282366A2 (de) 2000-05-10 2001-05-03 Zusammensetzungen enthaltend folsäure und reduziertes folat
CA002408401A CA2408401A1 (en) 2000-05-10 2001-05-03 Compositions containing folic acid and reduced folate
AU70501/01A AU782556B2 (en) 2000-05-10 2001-05-03 Compositions containing folic acid and reduced folate
US10/275,566 US6921754B2 (en) 2000-05-10 2001-05-03 Compositions containing folic acid and reduced folate
JP2001581632A JP2003532655A (ja) 2000-05-10 2001-05-03 葉酸および還元型フォレート（ｆｏｌａｔｅ）を含有する組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10022510A DE10022510A1 (de) 2000-05-10 2000-05-10 Zusammensetzungen enthaltend Folsäure und reduziertes Folat
DE10022510.1 2000-05-10

Publications (2)

Publication Number Publication Date
WO2001084962A2 WO2001084962A2 (de) 2001-11-15
WO2001084962A3 true WO2001084962A3 (de) 2002-04-11

Family

ID=7641274

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/004984 WO2001084962A2 (de) 2000-05-10 2001-05-03 Zusammensetzungen enthaltend folsäure und reduziertes folat

Country Status (8)

Country Link
US (1) US6921754B2 (de)
EP (1) EP1282366A2 (de)
JP (1) JP2003532655A (de)
AU (1) AU782556B2 (de)
CA (1) CA2408401A1 (de)
DE (1) DE10022510A1 (de)
WO (1) WO2001084962A2 (de)
ZA (1) ZA200209941B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69728379T2 (de) 1996-01-31 2005-02-24 South Alabama Medical Science Foundation, Mobile Lebensmittel und vitamin herstellungen mit natürlichem isomeren von reduzierten folaten
HUP0402674A3 (en) * 2002-02-21 2012-12-28 Bayer Schering Pharma Ag Pharmaceutical compositions comprising one or more steroids one or more tetrahydrofolate components and vitamin b12
CH696628A5 (de) * 2002-02-26 2007-08-31 Eprova Ag Verwendung von Folaten zur Herstellung einer Zubereitung geeignet zur Vorbeugung und Behandlung von Entzündungen und entzündungsassoziierter Krankheiten, im Speziellen zur Beeinflussung der
AU2003225726A1 (en) * 2002-03-11 2003-09-29 Lipomics Technologies, Inc. Novel metabolic targets and markers
DE102004041270A1 (de) 2004-08-26 2006-03-02 Merz Pharma Gmbh & Co. Kgaa Ein Kapillar- Wirksystem enthaltende Zusammensetzungen mit anwendungsbezogener Differenzierbarkeit und deren Verwendung
BRPI0608293A2 (pt) * 2005-03-10 2012-05-02 Sciele Pharma Inc preparações nutricionais
US20060217385A1 (en) * 2005-03-10 2006-09-28 Edwards John B Nutritional preparations
WO2006119589A2 (en) * 2005-05-11 2006-11-16 Ramaekers, Vincent Prevention and therapy of cerebral folate deficiency
UY29527A1 (es) * 2005-05-13 2006-12-29 Schering Ag Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
DE102005023301B4 (de) * 2005-05-13 2012-05-31 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Zusammensetzung enthaltend Gestagene und/oder Estrogene und 5-Methyl-(6S)-tetrahydrofolat
WO2008127699A1 (en) * 2007-04-11 2008-10-23 Ehrlich Shelley R Neural tube birth defect reduction with folic acid delivery in catamenial hygiene products
GB0715502D0 (en) * 2007-08-08 2007-09-19 Univ Manchester Methods
WO2011100550A2 (en) 2010-02-12 2011-08-18 Alexander Vuckovic, M.D., Llc Compositions and methods for treating depression
ITMI20111808A1 (it) * 2011-10-05 2013-04-06 Ati S R L Composizione alimentare priva di glutine e prodotti alimentari con essa preparati
MX354547B (es) 2011-11-14 2018-03-09 Alfasigma Spa Ensayos y métodos para seleccionar un regimen de tratamiento para un sujeto con depresión.
US20140073598A1 (en) * 2012-09-11 2014-03-13 Jaymac Pharmaceuticals Llc Multiple folate formulation and use thereof
US20160053281A1 (en) 2013-08-15 2016-02-25 The University Court Of The University Of Edinburgh Enhanced Expression Of RNA Vectors
WO2015136446A1 (en) 2014-03-11 2015-09-17 Nestec S.A. Methods for selecting antidepressant drug therapy to treat depression
PL411635A1 (pl) * 2015-03-18 2016-09-26 Sequoia Spółka Z Ograniczoną Odpowiedzialnością Kompozycja farmaceutyczna zawierająca kwas foliowy oraz sól glukozaminową kwasu (6S)-5-metylotetrahydrofoliowego oraz jej zastosowanie
AU2017397463B2 (en) 2016-11-03 2022-01-06 HedoniaUSA, Inc. Compositions and methods for treating depression
IT202000010228A1 (it) * 2020-05-07 2021-11-07 Inpha Res S R L Composizione per la prevenzione e il trattamento di condizioni da carenza di folati e/o vitamina b12, particolarmente iperomocisteinemia
CN115040489B (zh) * 2022-08-17 2022-10-25 北京罗诺强施医药技术研发中心有限公司 具有优良一致性的稳定药物组合物及其制法
WO2024175614A1 (en) * 2023-02-24 2024-08-29 Merck Patent Gmbh Stable liquid formulations comprising (6s)-5-methyltetrahydrofolic acid or salts thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010118A1 (de) * 1991-11-11 1993-05-27 Knoll Atiengesellschaft Verfahren zur trennung von 5-methyl-tetrahydrofolsäure
WO1997027764A1 (en) * 1996-01-31 1997-08-07 South Alabama Medical Science Foundation Food and vitamin preparations containing the natural isomer of reduced folates
WO1998019690A1 (en) * 1996-11-06 1998-05-14 Bristol-Myers Squibb Company Method for treating alzheimer's disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ208538A (en) * 1983-06-16 1987-08-31 Farley Health Products Liquid infant food containing vitamin b 2
TW264374B (de) 1993-10-05 1995-12-01 Ajinomoto Kk
JP2962159B2 (ja) * 1994-09-09 1999-10-12 味の素株式会社 肥育豚飼料用添加物および肥育豚用飼料
US5654011A (en) * 1996-07-30 1997-08-05 Energetics, Inc. Dietary supplements
WO1999037155A1 (en) 1998-01-27 1999-07-29 Nutramax Laboratories, Inc. Combinations of tyrosine, methylating agents, phospholipids, fatty acids, and st. john's wort for the treatment of mental disturbances

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010118A1 (de) * 1991-11-11 1993-05-27 Knoll Atiengesellschaft Verfahren zur trennung von 5-methyl-tetrahydrofolsäure
WO1997027764A1 (en) * 1996-01-31 1997-08-07 South Alabama Medical Science Foundation Food and vitamin preparations containing the natural isomer of reduced folates
WO1998019690A1 (en) * 1996-11-06 1998-05-14 Bristol-Myers Squibb Company Method for treating alzheimer's disease

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DAY B P F ET AL: "Thermal stability of folic acid and 5-methyltetrahydrofolic acid in liquid model food systems.", JOURNAL OF FOOD SCIENCE 1983 FOOD SCI. & HUMAN NUTR. DEP., UNIV. OF FLORIDA, GAINESVILLE, FLORIDA 32611, USA, vol. 48, no. 2, pages 581 - 587, 599, XP002182103 *
ROUSEFF R L ET AL: "HEALTH AND NUTRITIONAL BENEFITS OF CITRUS FRUIT COMPONENTS -CAROTENE, VITAMIN C, AND FOLIC ACID MAY PROVIDE PROTECTION AGAINST CANCER, HEART DESEASE, AND NEURAL TUBE DEFECTS", FOOD TECHNOLOGY, INSTITUTE OF FOOD TECHNOLOGISTS. CHICAGO, US, vol. 48, no. 11, 1 November 1994 (1994-11-01), pages 125 - 126,128-129,, XP000483356, ISSN: 0015-6639 *

Also Published As

Publication number Publication date
US6921754B2 (en) 2005-07-26
JP2003532655A (ja) 2003-11-05
US20030143304A1 (en) 2003-07-31
EP1282366A2 (de) 2003-02-12
ZA200209941B (en) 2004-03-09
AU7050101A (en) 2001-11-20
CA2408401A1 (en) 2002-11-06
WO2001084962A2 (de) 2001-11-15
DE10022510A1 (de) 2001-11-15
AU782556B2 (en) 2005-08-11

Similar Documents

Publication Publication Date Title
WO2001084962A3 (de) Zusammensetzungen enthaltend folsäure und reduziertes folat
IL210823A0 (en) [1,2,4] TRIAZOLO [4,3-a] PYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
AU2719300A (en) Antimicrobial compositions containing photosensitizers, articles, and methods ofuse
WO2004078120A3 (en) Collagen compositions and biomaterials
AU4504699A (en) Metallocene-catalyzed oligodecenes, their production and their use as component in lubricants
MXPA01007928A (es) Composiciones de recubrimiento de curado en dos etapas.
GB2361703B (en) Folic acid and/or vitamin B12-lactoferrin complex
MXPA03007848A (es) Derivados de quinolil propil piperidina, su preparacion y las composiciones que los contienen.
WO2003053394A3 (de) Verwendungen von apfelkernextrakten in kosmetischen oder pharmazeutischen zusammensetzungen
AU2001286701A1 (en) Hyaluronan-based antiadhesion compositions, their preparation and use
ZA200105538B (en) Compositions comprising flavylium salt compounds which are unsubstituted in Position 3, for colouring the skin, and uses thereof.
IL156536A0 (en) Pyrazolo [3,4-d] pyrimidin-4-one derivatives and pharmaceutical compositions containing the same
ZA200307306B (en) Indolines, substituted in portion 6, and their use as kinase inhibitors.
AU2001231902A1 (en) Composition for cosmetic or dermopharmaceutical use containing an imperata extract, in particular an imperata cylindrica l extract
MXPA04003499A (es) Utilizacion de cistationina.
IL161472A0 (en) In vitro micro-organs, and uses related thereto
WO2001091767A3 (en) Compositions for enhancing therapeutic effects containing herbals and/or nutritional supplements and/or minerals and/or vitamins
MXPA03009209A (es) Formulaciones de 3,7-diazabiciclo-[3.3.1] como compuestos anti-arritmicos.
ZA200002546B (en) Sorbate-preserved compositions, method for the manufacture thereof and their use.
PL362573A1 (en) Imidazolidine derivatives, their preparation, and their use as antinflamatory agent.
AU4884701A (en) Malonanilic acid derivatives, medicinal compositions containing the same and usethereof
WO2001091771A3 (en) Compositions for treating back and leg discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins
WO2003020767A3 (en) Antibodies against caspase-8, their preparation and use
EP1123695A3 (de) Orale Zusammensetzungen aus Kapseln, die Keratin enthalten
CA98132S (en) Tabletop folder/inserter

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 2001949308

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2408401

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 10275566

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 70501/01

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2002/09941

Country of ref document: ZA

Ref document number: 200209941

Country of ref document: ZA

WWP Wipo information: published in national office

Ref document number: 2001949308

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 70501/01

Country of ref document: AU

WWW Wipo information: withdrawn in national office

Ref document number: 2001949308

Country of ref document: EP